Observational analysis demonstrates reduced hyperuricemia in models with Lacticaseibacillus rhamnosus, suggesting a potential regulatory role in metabolic disorders.
Hyperuricemia is a growing metabolic disorder, whereas current microbiota-based strategies primarily focus on urate degradation or excretion, leaving upstream regulation of nucleoside precursors largely unexplored.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: